![Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure - New York Stem Cell Foundation Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure - New York Stem Cell Foundation](https://nyscf.org/wp-content/uploads/2020/03/groupshot_sm.jpg)
Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure - New York Stem Cell Foundation
![Antibody positive patients with type 2 diabetes who rapidly progress to insulin have similar characteristics and type 1 genetic risk scores as patients with type 1 diabetes - Media Centre | EASD Antibody positive patients with type 2 diabetes who rapidly progress to insulin have similar characteristics and type 1 genetic risk scores as patients with type 1 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1167_879603/Slide1.jpg)
Antibody positive patients with type 2 diabetes who rapidly progress to insulin have similar characteristics and type 1 genetic risk scores as patients with type 1 diabetes - Media Centre | EASD
![Type 1 diabetes staging classification opens door for intervention | TRIALNET Type 1 Diabetes TrialNet Type 1 diabetes staging classification opens door for intervention | TRIALNET Type 1 Diabetes TrialNet](https://www.trialnet.org/sites/default/files/styles/blog_list_feature_825x480_/public/2019-07/Blog7.png?itok=6rvQ3REB)
Type 1 diabetes staging classification opens door for intervention | TRIALNET Type 1 Diabetes TrialNet
![Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41574-020-00443-4/MediaObjects/41574_2020_443_Fig1_HTML.png)
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology
![Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP) | Scientific Reports Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP) | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-28907-8/MediaObjects/41598_2018_28907_Fig1_HTML.jpg)
Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP) | Scientific Reports
![Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era | Journal of Translational Medicine | Full Text Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-021-02778-6/MediaObjects/12967_2021_2778_Fig1_HTML.png)
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era | Journal of Translational Medicine | Full Text
![Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/e2a21372-5bd4-44a4-ae0e-088bddb9db3b/gr1.jpg)
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology
![Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories | Nature Communications Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28909-1/MediaObjects/41467_2022_28909_Fig1_HTML.png)
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories | Nature Communications
![Research progress: 1960s blood pressure drug could protect beta cells in type 1 diabetes - JDRF, the type 1 diabetes charity Research progress: 1960s blood pressure drug could protect beta cells in type 1 diabetes - JDRF, the type 1 diabetes charity](https://jdrf.org.uk/wp-content/uploads/2020/08/jdrf-type-1-diabetes-researchers-stephan-kissler-peng-yi.jpg)